Citation: | LIU Xin-xin, GAO Chun-ming, LIU Chuan-miao. Clinical characteristics of primary biliary cholangitis and RPR value in diagnosing cirrhosis[J]. Chinese Journal of General Practice, 2021, 19(3): 454-458. doi: 10.16766/j.cnki.issn.1674-4152.001834 |
[1] |
WANG L, GERSHWIN E M, WANG F S. Primary biliary cholangitis in China[J]. Curr Opin Gastroenterol, 2016, 32(3): 195-203. http://www.ncbi.nlm.nih.gov/pubmed/26885951
|
[2] |
WANG H, XU H Q, WANG X M, et al. Red blood cell distribution width to platelet ratio is related to histologic severity of primary biliary cirrhosis[J]. Medicine(Baltimore), 2016, 95(11): e3114. http://www.scienceopen.com/document_file/5c0e919c-1c82-4eb7-bf2d-19764668cdd5/PubMedCentral/5c0e919c-1c82-4eb7-bf2d-19764668cdd5.pdf
|
[3] |
HIRSCHFIELD G M, BEUERS U, CORPECHOT C, et al. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis[J]. J Hepatol, 2017, 67(1): 145-172. doi: 10.1016/j.jhep.2017.03.022
|
[4] |
徐小元, 丁惠国, 李文刚, 等. 肝硬化诊治指南[J]. 临床肝胆病杂志, 2019, 35(11): 2408-2425. doi: 10.3969/j.issn.1001-5256.2019.11.006
|
[5] |
ABDULKARIM M, ZENOUZI R, SEBODE M, et al. Sex differences in clinical presentation and prognosis in patients with primary biliary cholangitis[J]. Scand J Gastroenterol, 2019, 54(11): 1391-1396. doi: 10.1080/00365521.2019.1683226
|
[6] |
GATSELIS N K, GOET J C, ZACHOU K, et al. Factors associated with progression and outcomes of early stage primary biliary cholangitis[J]. Clin Gastroenterol Hepatol, 2020, 18(3): 684-692, 696. doi: 10.1016/j.cgh.2019.08.013
|
[7] |
LOAEZA-DEL C A, GAYTAN-SANTILLAN A, LOPEZ-TELLO A, et al. Patterns of serum lipids derangements and cardiovascular risk assessment in patients with primary biliary cholangitis[J]. Ann Hepatol, 2019, 18(6): 879-882. doi: 10.1016/j.aohep.2019.07.006
|
[8] |
鲁丹, 万彦彬, 杨小金, 等. 原发性胆汁性肝硬化合并自身免疫性疾病患者免疫学指标及补体水平研究[J]. 检验医学与临床, 2016, 13(13): 1829-1831. doi: 10.3969/j.issn.1672-9455.2016.13.032
|
[9] |
TANG L, ZHONG R, HE X, et al. Evidence for the association between IgG-antimitochondrial antibody and biochemical response to ursodeoxycholic acid treatment in primary biliary cholangitis[J]. J Gastroenterol Hepatol, 2017, 32(3): 659-666. doi: 10.1111/jgh.13534
|
[10] |
李京华, 赵伟, 童晶晶, 等. 原发性胆汁性肝硬化发生失代偿的危险因素研究[J]. 检验医学, 2018, 33(5): 399-403. https://www.cnki.com.cn/Article/CJFDTOTAL-SHYY201805006.htm
|
[11] |
张帅, 郭冠亚, 周霞, 等. 原发性胆汁性胆管炎家系筛查及其低频突变的全外显子组测序研究[J]. 中华肝脏病杂志, 2018, 26(5): 388-392. doi: 10.3760/cma.j.issn.1007-3418.2018.05.014
|
[12] |
CELIK D, TATAR B, KOSE S, et al. Evaluation of the diagnostic validity of noninvasive tests for predicting liver fibrosis stage in chronic hepatitis B patients[J]. Acta Gastroenterol Belg, 2020, 83(3): 419-425. http://www.researchgate.net/publication/345145444_Evaluation_of_the_diagnostic_validity_of_noninvasive_tests_for_predicting_liver_fibrosis_stage_in_chronic_hepatitis_B_patients
|
[13] |
WANG H L, WANG J, XIA J, et al. Red cell distribution width to platelet ratio predicts liver fibrosis in patients with autoimmune hepatitis[J]. Medicine(Baltimore), 2020, 99(34): e21408. http://journals.lww.com/md-journal/Fulltext/2020/08210/Red_cell_distribution_width_to_platelet_ratio.12.aspx
|
[14] |
申波, 蒋廷旺. RDW与RPR在原发性胆汁性胆管炎病理分期严重程度判定中的价值[J]. 国际检验医学杂志, 2020, 41(6): 751-754. doi: 10.3969/j.issn.1673-4130.2020.06.030
|
[15] |
HUANG C Y, HAN W J, WANG C M, et al. Early prognostic utility of gp210 antibody-positive rate in primary biliary cholangitis: A meta-analysis[J]. Dis Markers, 2019, 2019: 9121207. http://www.ncbi.nlm.nih.gov/pubmed/31737133
|
[16] |
YANG F, YANG Y, WANG Q, et al. The risk predictive values of UK-PBC and GLOBE scoring system in Chinese patients with primary biliary cholangitis: the additional effect of anti-gp210[J]. Aliment Pharmacol Ther, 2017, 45(5): 733-743. doi: 10.1111/apt.13927
|
[17] |
卢慧, 张文. 抗着丝点抗体在多种疾病的临床意义[J]. 中华临床免疫和变态反应杂志, 2018, 12(6): 650-654. https://www.cnki.com.cn/Article/CJFDTOTAL-OZHL201806032.htm
|
[18] |
CHEN C T, TSENG Y C, YANG C W, et al. Increased risks of spontaneous bacterial peritonitis and interstitial lung disease in primary biliary cirrhosis patients with concomitant sjogren syndrome[J]. Medicine(Baltimore), 2016, 95(2): e2537. http://www.onacademic.com/detail/journal_1000038709880210_2355.html
|
[19] |
涂荣芳, 杨雪, 唐映梅. 原发性胆汁性胆管炎合并肝外自身免疫性疾病的研究进展[J]. 临床肝胆病杂志, 2020, 36(6): 1398-1401. doi: 10.3969/j.issn.1001-5256.2020.06.046
|
[20] |
FAN X, MEN R, NI P, et al. Concomitant systemic lupus erythematosus might have a negative impact on the biochemical responses to treatment in patients with primary biliary cholangitis[J]. Clin Rheumatol, 2020, 39(3): 795-803. doi: 10.1007/s10067-019-04853-2
|
[21] |
HARMS M H, VAN BUUREN H R, CORPECHOT C, et al. Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis[J]. J Hepatol, 2019, 71(2): 357-365. doi: 10.1016/j.jhep.2019.04.001
|